Health risks fade after hormone therapy stops

after ending the treatment. Women randomly assigned to take hormone therapy used Premarin, a hormone therapy made by Wyeth, a pharmaceutical company now owned by Pfizer. During the treatment, stroke was 36 percent more likely and blood clots were 47...